Mr. Mark Billings reports

AUDITED FINANCIAL STATEMENTS: MARCH 31, 2023 RESULTS

ZeU Technologies Inc. is informing its shareholders that it has posted its audited financial statements for the year ended March 31, 2023, and the 15-month period ended March 31, 2022, and the corresponding management's discussion and analysis, on SEDAR.

ZeU Technologies as a going concern

Since the withdrawal of the proposed transaction with a Chinese entity in August, 2018, management has been forced to operate with limited capabilities. From having to define from scratch, and finance and develop a new business model to the coming deployment of some of its products, the company has been limited in its capacity to conclude acquisitions and see to its financing needs due to the existence of a significant debt related and inherited from the proposed founding transaction.

Attempts to mitigate the situation and renegotiate the last important block of debts owed since the maturation of the 2018 debentures in 2020 have failed.

No compensation is currently paid to directors, management, consultants or employees. Important amounts accrued and related to compensation to management and consultants have been eliminated through mutual agreements with the creditors.

On March 31, 2023, the largest group of creditors agreed to convert almost $10-million of debt against the issuance of 4.13 million shares of the company and a promissory note of $175,000 with a payment schedule spread over two years. The initial payment has been met, but the company failed to meet its payment obligation on June 15, 2023.

Current design and development are severely hindered as all external developers have been furloughed for more than three quarters and the company must rely on directors who volunteer to advance the development and negotiations with no financial resources being available.

Financial results overview

Summary of the results of operation

For the year ended March 31, 2023, the company recorded a net gain of $4,988,774 (2022: $14,274,215 loss) and had accumulative deficit of $26,227,388 (2022: $31,216,162).

An attached table provides a summary of the company's financial operations for the prior two fiscal years.

12 months ended March 31, 2023

The company incurred a net gain of $4,988,774 in the year. Operating expenses were $2,699,541, and the company recorded a gain of $8,020,949 in the debt settlements and recognized a loss of $446,400 in the impairment of intangible assets.

15 months ended March 31, 2022

The company incurred a net loss of $14,274,215 in the 15 months. Operating expenses were $5,790,195, and the company recognized a loss of $23,755 upon the sale of certain marketable securities. The company also recorded a recognized gain of $4,491,806 on the repayment of $3,917,000 Kamari convertible debentures plus accrued interest by transferring 18,705,115 Kamari tokens to the debentureholder. The company recognized a loss of $13,320,813 on the impairment of goodwill in a subsidiary.

Summary of the quarterly results

An attached table outlines selected unaudited financial information of the company for the last eight quarters.

The main factors contributing to variances to the quarters up to March 31, 2023, were a gain of $8,020,949 in the debt settlement on March 31, 2023, a gain on the Kamari convertible debt settlement in March, 2022, of $3,391,988, a loss of $13,320,813 on impairment of goodwill in March, 2022, a loss of $23,874 on sale of marketable securities in Sept. 30, 2021, and stock-based compensation of $727,630 in June 30, 2021.

About ZeU Technologies Inc.

ZeU Technologies is a forward-thinking Canadian technology company that has developed a state-of-the-art DLT protocol, providing the foundation for the next generation of encrypted and distributed networks. As a result of its high level of sophistication, ZeU Technologies' technology maximizes transparency, security and scalability, as well as big data management. ZeU Technologies' strategy is to monetize DLT transactions in diverse sectors such as payment, gaming, data and health care.